An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease.
非透析依賴型慢性腎臟病貧血治療中促缺氧誘導因子脯氨酸羟化酶抑制劑的療效和安全性更新的荟萃分析。
Ren Fail 2023-09-23
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
慢性腎臟病患者的貧血治療之旅:從紅細胞生成素到缺氧誘導因子-脯氨酸羟化酶抑制劑。
Clin Kidney J 2023-10-03
The importance of early diagnosis and intervention in chronic kidney disease: Calls-to-action from nephrologists based mainly in Central/Eastern Europe.
慢性腎臟病的早期診斷和干預的重要性:來自主要位於中東歐的腎臟病專家的號召。
Kidney Blood Press Res 2024-03-05
Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study.
穩定低氧誘導因子以管理慢性腎臟病貧血:從基本理論到臨床研究。
Kidney Dis (Basel) 2024-04-25
Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance.
慢性腎病中的貧血與生活品質:來自歐洲CKD貧血聯盟的共識文件。
Clin Kidney J 2024-08-13
The Broader Effects of Delayed Progression to End-Stage Kidney Disease: Delaying the Inevitable or a Meaningful Change?
延遲進展至末期腎病的更廣泛影響:延遲不可避免的結果還是有意義的改變?
Adv Ther 2024-08-14
Association between timing of vascular access creation and mortality in patients initiating hemodialysis: A nationwide cohort study in Japan.
血管通路建立時機與開始透析患者死亡率之間的關聯:日本全國性隊列研究。
Am J Nephrol 2024-09-08